Last reviewed · How we verify
Lorazepam CI
At a glance
| Generic name | Lorazepam CI |
|---|---|
| Also known as | Ativan |
| Sponsor | The Emmes Company, LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Lorazepam Sedation for Critically Ill Children (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lorazepam CI CI brief — competitive landscape report
- Lorazepam CI updates RSS · CI watch RSS
- The Emmes Company, LLC portfolio CI